相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 954, 2018)
Ali H. Mokdad
LANCET NEUROLOGY (2021)
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study
Dawn C. Buse et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life - A Case Study of the Innovative Medicines Initiative
Michael Happich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
Hans-Christoph Diener et al.
CEPHALALGIA (2020)
Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
Marta Torres-Ferrus et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Migraine day frequency in migraine prevention: longitudinal modelling approaches
Gian Luca Di Tanna et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
Hans-Christoph Diener et al.
CEPHALALGIA (2019)
Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece
Theodoros V. Giannouchos et al.
CLINICAL DRUG INVESTIGATION (2019)
Migraine Epidemiology, Burden, and Comorbidity
Rebecca C. Burch et al.
NEUROLOGIC CLINICS (2019)
Migraine Progression: A Systematic Review
Dawn C. Buse et al.
HEADACHE (2019)
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre
Andrea Negro et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Cristina Tassorelli et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
Machaon Bonafede et al.
HEADACHE (2018)
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
David Cameron et al.
GLOBAL HEALTH ACTION (2018)
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study
Kasper Adelborg et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study
Kasper Adelborg et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Pamela Vo et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ)
Asha Hareendran et al.
HEADACHE (2018)
Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Joseph Raymond Zunt et al.
LANCET NEUROLOGY (2018)
Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs)
Kirstie L. Haywood et al.
CEPHALALGIA (2018)
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Lars Jacob Stovner et al.
LANCET NEUROLOGY (2018)
Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary
Ariane K. Kawata et al.
HEADACHE (2017)
Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine-the migraine physical function impact diary (MPFID)
Asha Hareendran et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
Daniel Serrano et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Valery L. Feigin et al.
LANCET NEUROLOGY (2017)
Comorbid pain and migraine chronicity The Chronic Migraine Epidemiology and Outcomes Study
Ann I. Scher et al.
NEUROLOGY (2017)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare
Matthijs Versteegh et al.
PHARMACOECONOMICS (2016)
Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China
Z. He et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Meta-analysis of the heritability of human traits based on fifty years of twin studies
Tinca J. C. Polderman et al.
NATURE GENETICS (2015)
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
Tessa Kennedy-Martin et al.
TRIALS (2015)
Supplement 4: Canadian Guidelines on Parkinson's Disease
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2014)
What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients
Antonia F. H. Smelt et al.
CEPHALALGIA (2014)
What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study
Antonia F. H. Smelt et al.
PLOS ONE (2014)
Preventive Pharmacologic Treatments for Episodic Migraine in Adults
Tatyana A. Shamliyan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2013)
The cost of headache disorders in Europe: the Eurolight project
M. Linde et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Validating Migraine-Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
Christine L. Bagley et al.
HEADACHE (2012)
EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs
Megan R. Stafford et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Italian guidelines for primary headaches: 2012 revised version
Paola Sarchielli et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
James E. Signorovitch et al.
VALUE IN HEALTH (2012)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
A. M. Blumenfeld et al.
CEPHALALGIA (2011)
EuroQol (EQ-5D) health utility scores for patients with migraine
Ruifeng Xu et al.
QUALITY OF LIFE RESEARCH (2011)
Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version 2.1
J. C. Cole et al.
CEPHALALGIA (2009)
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial
Hans-Christoph Diener et al.
LANCET NEUROLOGY (2007)
Efficacy of eletriptan in migraine-related functional impairment: Functional and work productivity outcomes
Stephen D. Silberstein et al.
HEADACHE (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test
RR Coeytaux et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Economic impact of migraine and other episodic headaches in France - Data from the GRIM2000 study
A Pradalier et al.
PHARMACOECONOMICS (2004)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers
WF Stewart et al.
PAIN (2000)
分享论文
